Richard Friedman to Patient Selection
This is a "connection" page, showing publications Richard Friedman has written about Patient Selection.
Connection Strength
0.022
-
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag. 2014; 10:157-67.
Score: 0.022